HIV Treatment and Prevention Agents Hospitals Immunization Vaccines 
Pharmacy Friday Pearls
MARCH 4, 2022
18 years Administration Oral Oral Oral PK/PD MOA: Nirmatrelvir – inhibitor of the SARS-CoV-2 main protease Prevents viral replicationRitonavir is a CYP3A inhibitor included to increase nirmatrelvir plasma levelsRitonavir alone has NO activity against SARS-CoV-2 Time to peak: Nirmatrelvir: 3 hrs & Ritonavir: 3.98 Introduction.
The Checkup by Singlecare
FEBRUARY 6, 2023
Pneumonia is often mild to moderate, requiring only outpatient treatment. Rarely can it be severe enough to require intensive care in a hospital? Risk factors of pneumonia are age older than 65, chronic obstructive pulmonary disorder ( COPD ), HIV infection , weakened immune system and smoking.
Expert insights. Personalized for you.
40 
Let's personalize your content